Chemoimmunotherapy for esophageal squamous cell carcinoma—Summary and discussion of recent clinical trials

Chemoimmunotherapy for esophageal squamous cell carcinoma—Summary and discussion of recent clinical trials

Abstract As a kind of carcinoma with increasing morbidity, poor prognosis, and high mortality, esophageal squamous cell carcinoma (ESCC) is challenging for clinical management. Chemotherapy has been the standard treatment for ESCC over decades, while its clinical outcomes remain unsatisfying. And th...

Full description

Bibliographic Details
Main Authors: Zhen Zhang, Jiaqian Huang, Yuhong Xu, Huiyan Luo
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:MedComm – Future Medicine
Subjects:
chemoimmunotherapy
esophageal squamous cell carcinoma
immunotherapy
PD‐1
PD‐L1
Online Access:https://doi.org/10.1002/mef2.56

Similar Items

Similar Items